DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Peptilogics
Peptilogics
Stage unknownUS
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- $78.0Msum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Oct 16, 2025Funding round · $78.0M (disclosed)Narya Capital Management, LLC (participant)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial”
Investors on record
1 edges
- Narya Capital Management, LLC round, participant Fact prnewswire.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Oct 16, 2025Peptilogics announced Funding round of $78,000,000Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company
- Round announced: Funding round $78,000,000 Oct 16, 2025 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)